Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
30 participants
INTERVENTIONAL
2025-07-15
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Opioids Following ACL
NCT04278703
Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery
NCT04246554
Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction
NCT03818932
Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery
NCT04246541
Opiates Prescribing for Knee Arthroscopies and ACL Reconstruction
NCT03876743
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxycodone- Narcotic
Arm 1
Ketorolac
Patients will be randomized to either Ketorolac or Oxycodone
Ketorolac
Arm 2
dispense of study drug
• Cohort Group 1 (Experimental): ketorolac 10mg with rescue medication oxycodone 5mg All patients will be given acetaminophen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dispense of study drug
• Cohort Group 1 (Experimental): ketorolac 10mg with rescue medication oxycodone 5mg All patients will be given acetaminophen
Ketorolac
Patients will be randomized to either Ketorolac or Oxycodone
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Male or female, aged 15-55 years
* Primary Autograft ACL surgery
* Ability to take oral medication and willingness to patriciate in a virtual 1 and 2 week follow-up pill counts
Exclusion Criteria
* Stated willingness to comply with all study procedures and availability for t the duration of the study
* Male or female, aged 15-55 years
* Primary Autograft ACL surgery
* Ability to take oral medication and willingness to patriciate in a virtual 1 and 2 week follow-up pill counts
15 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kurt Spindler, MD
Lead Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kurt P Spindler, MD
Role: PRINCIPAL_INVESTIGATOR
The Cleveland Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic Coral Springs
Coral Springs, Florida, United States
Cleveland clinic sports medicine
Garfield, Ohio, United States
Cleveland Clinic
Strongsville, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-1207
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.